MedPath
FDA Approval

ALISKIREN

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 25, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Aliskiren(300 mg in 1 1)

Products2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ALISKIREN

Product Details

NDC Product Code
49884-425
Application Number
ANDA206665
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 25, 2019
AliskirenActive
Code: C8A0P8G029Class: ACTIMQuantity: 300 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
CALCIUM STEARATEInactive
Code: 776XM7047LClass: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6Class: IACT
CROSPOVIDONE, UNSPECIFIEDInactive
Code: 2S7830E561Class: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3BClass: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT

ALISKIREN

Product Details

NDC Product Code
49884-424
Application Number
ANDA206665
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
March 25, 2019
AliskirenActive
Code: C8A0P8G029Class: ACTIMQuantity: 150 mg in 1 1
CALCIUM STEARATEInactive
Code: 776XM7047LClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
CROSPOVIDONE, UNSPECIFIEDInactive
Code: 2S7830E561Class: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675Class: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3BClass: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357Class: IACT
© Copyright 2025. All Rights Reserved by MedPath